← Eichor
Condition: Periprosthetic Joint Infection Pji Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Periprosthetic Joint Infection Pji

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants
Phase 1/Phase 2 · 1 location(s) · TenNor Therapeutics Inc. · NCT06889701Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant
Phase 2/Phase 3 · 14 location(s) · Peptilogics · NCT07214311Rifampin-combined Antibiotic Therapy for Staphylococcal PJI
NA · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07313215Molecular Biology in the Identification of Pathogens at Reimplantation in the Two-Stage Treatment of Periprosthetic Infe
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06804265Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
Phase N/A · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT05284318
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.